Ads
related to: Latest Treatment Copd- Sign Up For Updates
Receive The Latest Updates For This
COPD Maintenance Option.
- Savings Card Offer
Review Eligibility & Access Terms
For Your Patients.
- COPD Treatment Option
Explore Clinical Study Data To
Learn More About This Option.
- Administration Info
Physicians: Review Important
Dosing & Admin Information.
- Sampling Made Simple
Visit The Site To Learn How You Can
Request Samples.
- Physician Resources
Access Useful Resources For You &
Your COPD Patients.
- Sign Up For Updates
Search results
How To Be Active in Your Treatment Journey With COPD
Parade via Yahoo News· 5 months agoGordon Stewart-Harrison recalls his first experience with chronic obstructive pulmonary disease (COPD) when he was shoveling snow on his driveway. After...
Regeneron's (REGN) Dupixent Meets Pivotal COPD Study Goal, Up 7%
Zacks via Yahoo Finance· 1 year agoRegeneron's (REGN) share price rose after it reported data from a late-stage study showing that...
Emergency Medicine: For some with COPD, quitting smoking is major first step to health
The Columbus Dispatch via Yahoo News· 1 year agoI overheard the EMS radio calling in to the emergency department and could immediately hear the...
What to know about COPD after Eagles co-founder Randy Meisner died of complications from the disease
ABC News via Yahoo News· 9 months agoRandy Meisner, a founding member of the Eagles, died of complications due to chronic obstructive...
How Is COPD Diagnosed?
Health via Yahoo News· 1 year agoMedically reviewed by Susan Russell, MD COPD is diagnosed based on your signs and symptoms, history of smoking and exposure to lung irritants, family...
Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL
Zacks via Yahoo Finance· 1 year agoThis week, Sanofi SNY and partner Regeneron’s REGN blockbuster medicine, Dupixent succeeded in a...
These Inhalers No Longer Cost More Than $35 Per Month
Verywell Health via Yahoo News· 1 month agoGrace Cary / Getty Images Fact checked by Nick Blackmer Key Takeaways Three major pharmaceutical...
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data
Reuters via Yahoo News· 1 year ago(Reuters) -Sanofi's asthma drug Dupixent met all targets in a trial to treat "smoker's lung",...
Could This New Drug Launch Be a Hit for Viatris?
Motley Fool· 1 year agoLast December, Viatris (NASDAQ: VTRS) and Kindeva Drug Delivery lost in court against AstraZeneca (NASDAQ: AZN) over a patent dispute regarding one of...
3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2024
Zacks via Yahoo Finance· 4 months agoThe biotech sector took a beating in 2023. Rising interest rates and inflation, global supply chain...
